TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE D-

NCT07520110: Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

Sponsor: University of Massachusetts, Worcester · Phase: PHASE3 · Area: IMMUNOLOGY · Target Enrollment: 800 pts

Competing Trials Overlap

10 Active Trials

Excess Burn Exposure

$15,676,800

Rescue Site Savings

+$10,336,890

Unlock Full NCT07520110 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07520110 Rescue Dossier →